Mitochondrial carbonic anhydrase–VB inhibition rescues brain endothelial stress and memory in Alzheimer’s disease models
Science Advances · 2026
DOI: 10.1126/sciadv.ady1161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Nicole L Lemon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Alzheimer's Center at Temple, Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Mitochondria, Brain, Endothelial Cells. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Institutes of Health.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder with no effective cure, characterized by the cerebral parenchymal and vascular accumulation of aggregated amyloid-β (Aβ) and hyperphosphorylated tau. Cerebrovascular and mitochondria dysfunction are early causal events in the progression of AD. Previous studies support that inhibiting carbonic anhydrases (CAs) may prevent mitochondrial and cerebrovascular dysfunction in AD models. Here, we selectively target the mitochondrial CA isoform CA-VB by pharmacological and genetic manipulation in human cerebral microvascular endothelial cells (hCMEC), and we confirm the protective effects of the CA-V inhibitor in AD mice. CA-V inhibition and CA-VB KO prevent Aβ induced mitochondria-mediated endothelial apoptosis, loss of barrier resistance, and hCMEC inflammatory activation. Strikingly, CA-V inhibition also mitigates caspase activation and endothelial cell activation in the brains of 3xTg AD mice, resulting in preserved memory function. Our results demonstrate that selective CA-V inhibition is an effective and promising strategy against AD-mediated cerebrovascular pathology, neuroinflammation and cognitive impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Alzheimer's Center at Temple, Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
- Department of Pharmaceutical Sciences and Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Temple University, Philadelphia, PA, USA.
ORCID-Profile: Nicole L Lemon, Elisa Canepa, Rebecca Parodi-Rullán, Tina Hirt, Lisa M Petersohn, Tashnuva Rifat, Maryam H Abyaneh, Marc A Ilies, Silvia Fossati
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- National Institutes of Health
- Alzheimer's Association
- Pennsylvania Department of Health
- Edward N. and Della L. Thome Memorial Foundation
- Karen Toffler Charitable Trust
Zitieren
APA
Lemon, N. L., Canepa, E., Vázquez-Torres, R., Parodi-Rullán, R., Hirt, T., Petersohn, L. M., Rifat, T., Abyaneh, M. H., Ilies, M. A., & Fossati, S. (2026). Mitochondrial carbonic anhydrase–VB inhibition rescues brain endothelial stress and memory in Alzheimer’s disease models. Science Advances. https://doi.org/10.1126/sciadv.ady1161
Vancouver
Lemon NL, Canepa E, Vázquez-Torres R, Parodi-Rullán R, Hirt T, Petersohn LM, et al. Mitochondrial carbonic anhydrase–VB inhibition rescues brain endothelial stress and memory in Alzheimer’s disease models. Science Advances. 2026. doi:10.1126/sciadv.ady1161
BibTeX
@article{Lemon2026,
author = {Lemon, Nicole L and Canepa, Elisa and Vázquez-Torres, Rafael and Parodi-Rullán, Rebecca and Hirt, Tina and Petersohn, Lisa M and Rifat, Tashnuva and Abyaneh, Maryam H and Ilies, Marc A and Fossati, Silvia},
title = {Mitochondrial carbonic anhydrase–VB inhibition rescues brain endothelial stress and memory in Alzheimer’s disease models},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.ady1161}
}
EUVIMED